Search for Clinical Trial Results

Sponsored By

Central Serous Chorioretinopathy - 25 Studies Found

Status Study
Completed Study Name: High-dose Antioxidants for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Date: 2009-08-20
Interventions: Drug: antioxidants tablets vitamin A 6600 IU, vitamin C 400 mg, vitamin E 150 IU, riboflavin 10 mg, zinc
Completed Study Name: Methotrexate for Central Serous Chorioretinopathy Treatment Trial
Condition: Central Serous Chorioretinopathy
Date: 2012-07-02
Interventions:
  • Drug: Methotrexate 7.5 mg per

Recruiting Study Name: Short-Term Oral Mifepristone for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Date: 2015-01-29
Interventions:
  • Drug: Mifepristone
  • Drug: Placebo
Completed Study Name: Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
Condition: Chronic Central Serous Chorioretinopathy
Date: 2007-06-20
Interventions:
  • Drug: Anecortave Acetate Sterile suspension 15 mg

Recruiting Study Name: Eplerenone for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Date: 2013-03-25
Interventions: Drug: Eplerenone 50mg All patients will receive the same dose of eplerenone.
Recruiting Study Name: The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Date: 2012-06-26
Interventions: Procedure: Photodynamic therapy Photodynamic therapy is performed using verteporfin. Full dose of vertep
Completed Study Name: Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Date: 2008-11-12
Not yet recruiting Study Name: A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Date: 2014-08-11
Interventions:
  • Drug: Eplerenone
  • Drug: Maltodextrin
Completed Study Name: Eplerenone for the Treatment of Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Date: 2013-11-15
Interventions:
  • Drug: 25mg Eplerenone Patients
Completed Study Name: Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy
Condition: Central Serous Chorioretinopathy
Date: 2009-11-19
Interventions:
  • Drug: Verteporfin PDT, half-dose

Next >>>